Gabelli Funds’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
Gabelli Funds's IMDZ Position: Q2 2019 in Review
Gabelli Funds sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,311,069 shares — an estimated $7.67M sold.
Gabelli Funds first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $7.67M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Gabelli Funds reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Gabelli Funds sold 1,311,069 Immune Design Corp. shares in Q2 2019, an estimated $7.67M.
- Gabelli Funds first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
- Gabelli Funds's Immune Design Corp. position peaked at $7.67M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.